Cargando…
Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study
BACKGROUND: The management of Klebsiella pneumoniae carbapenemase producing (KPC) infections represents a major challenge. Several safety and efficacy concerns are shared by available antibiotics used in KPC infections, leading to the occurrence of serious adverse drug reactions (ADRs), with ceftazi...
Autores principales: | Gatti, Milo, Raschi, Emanuel, De Ponti, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852729/ https://www.ncbi.nlm.nih.gov/pubmed/31718688 http://dx.doi.org/10.1186/s40360-019-0364-0 |
Ejemplares similares
-
Genomic Epidemiology of an Endoscope-Associated Outbreak of Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae
por: Marsh, Jane W., et al.
Publicado: (2015) -
Emergence of Klebsiella pneumoniae clinical isolates producing KPC-2 carbapenemase in Cuba
por: Quiñones, D, et al.
Publicado: (2014) -
Genomic epidemiology of global Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli
por: Stoesser, N., et al.
Publicado: (2017) -
Carbapenemase producing Klebsiella pneumoniae (KPC) meningitis from chronic otitis media
por: Anwar, Shamsuddin, et al.
Publicado: (2020) -
Carbapenemase-producing Klebsiella pneumoniae
por: Robilotti, Elizabeth, et al.
Publicado: (2014)